Differences in tenofovir trough concentrations between branded and generic formulations in people taking PrEP
AIDS
.
2021 Mar 1;35(3):522-524.
doi: 10.1097/QAD.0000000000002758.
Authors
Dario Cattaneo
1
,
Pietro Vinti
2
3
,
Sara Baldelli
1
,
Marta Fusi
1
,
Donatello Zagato
2
,
Anna De Bona
4
,
Elisa Suardi
4
,
Simona Bossolasco
5
,
Giuseppe Ancona
4
,
Roberto Rossotti
6
,
Massimo Cernuschi
2
3
5
,
Cristina Gervasoni
1
Affiliations
1
ASST Fatebenefratelli Sacco University Hospital.
2
Associazione Solidarietà AIDS Onlus.
3
Milano Checkpoint.
4
ASST Santi Paolo e Carlo.
5
IRCCS San Raffaele Scientific Institute.
6
ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
PMID:
33507010
DOI:
10.1097/QAD.0000000000002758
No abstract available
MeSH terms
Drugs, Generic
Emtricitabine
HIV Infections* / drug therapy
Humans
Pre-Exposure Prophylaxis*
Tenofovir
Substances
Drugs, Generic
Tenofovir
Emtricitabine